Bayer settles Roundup cancer lawsuits for up to $10.9 billion

The settled cases account for about 95% of those currently set for trial, it added.

News Wires's avatarPressok

Bayer AG agreed to settle U.S. lawsuits claiming that its widely-used weedkiller Roundup caused cancer for as much as $10.9 billion after more than a year of talks, resolving litigation that has hit the company’s share price.

The German drugs and pesticides maker has come to terms with about 75% of the current Roundup plaintiffs, involving about 125,000 filed and unfiled claims overall, it said in a statement on Wednesday.

The German drugs and pesticides maker has come to terms with 
about 75% of the current Roundup plaintiffs.
The German drugs and pesticides maker has come to terms with about 75% of the current Roundup plaintiffs. © Mark RALSTON AFP

The settled cases account for about 95% of those currently set for trial, it added.

“The Roundup settlement is the right action at the right time for Bayer to bring a long period of uncertainty to an end,” Bayer Chief Executive Werner Baumann said.

The company added it will make a payment of $8.8-$9.6 billion to resolve the…

View original post 28 more words

2 thoughts on “Bayer settles Roundup cancer lawsuits for up to $10.9 billion

  1. Brett, it’s my understanding that RoundUp primarily has its effect by killing gut bacteria that are essential for immunity (ie your body loses the ability to destroy the cancer). It poisons the shikimata pathway, which is fundamental to the basic metabolism of many bacteria. Monsanto has always bragged that Roundup is safe because human beings have no shikimata metabolic loop – but this fails to take account of “new” (known for nearly 2 decades) information revealing how important gut bacteria are to human health.

    Like

Leave a reply to stuartbramhall Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.